Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Sumit K. Chanda, Shuofeng Yuan et al.|Nature|2020Cited by 856
Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2Aimee L. Eggler, Andrew D. Mesecar, Guowen Liu et al.|Proceedings of the National Academy of Sciences|2005Cited by 451